Meet
Features
Solutions
Pricing
Sales Intelligence
Qualify prospects and connect with decision makers effortlessly
Research Companies & Directors
Make important decisions with absolute confidence
Create B2B Marketing Lists
Target and reach more of your ideal prospects than ever
Monitor Risks & Opportunities
Be the first to learn about changes in the companies that matter
Cleanse Your B2B Database
Instantly transform old records into new opportunities
Perform KYC Checks
Completely understand who you're working with
Discover New Businesses
Identify and connect with new companies as soon as they register
Company Credit Reports
See how companies are performing year–on–year and explore their debts
UPGRADE
Contact
Credit Report
Financials
People
Ownership
Latest Activity
Mutual Companies
Documents
Repayment History
Celleron Therapeutics Limited
Celleron Therapeutics Limited is an active company incorporated on 24 June 2004 with the registered office located in Oxford, Oxfordshire. Celleron Therapeutics Limited was registered 21 years ago.
Watch Company
Status
Active
Active since
18 years ago
Company No
05162047
Private limited company
Age
21 years
Incorporated
24 June 2004
Size
Micro
Turnover is under
£1M
Balance sheet is under
£500,000
Under
10 employees
Confirmation
Submitted
Dated
24 June 2025
(4 months ago)
Next confirmation dated
24 June 2026
Due by
8 July 2026
(7 months remaining)
Last change occurred
2 years 4 months ago
Accounts
Submitted
For period
1 Jul
⟶
31 Dec 2024
(1 year 6 months)
Accounts type is
Total Exemption Full
Next accounts for period
31 December 2025
Due by
30 September 2026
(10 months remaining)
Learn more about Celleron Therapeutics Limited
Contact
Update Details
Address
Magdalen Centre Robert Robinson Avenue
Oxford Science Park
Oxford
OX4 4GA
England
Address changed on
24 May 2024
(1 year 5 months ago)
Previous address was
Companies in OX4 4GA
Telephone
07860286799
Email
Available in Endole App
Website
Cellerontherapeutics.com
See All Contacts
People
Officers
2
Shareholders
1
Controllers (PSC)
1
William John Robert Fleming
Director • Chief Financial Officer • British • Lives in UK • Born in Oct 1966
Prof Nicholas Barrie La Thangue
Director • British • Lives in UK • Born in Nov 1957
Ingenox Therapeutics Limited
PSC
See Key People
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
See All Shareholders, PSCs & Group Structure
Mutual Companies
Argonaut Therapeutics Limited
Prof Nicholas Barrie La Thangue and William John Robert Fleming are mutual people.
Active
Ingenox Therapeutics Limited
Prof Nicholas Barrie La Thangue and William John Robert Fleming are mutual people.
Active
Canivax Limited
Prof Nicholas Barrie La Thangue is a mutual person.
Active
Oxford Cancer Biomarkers Limited
Prof Nicholas Barrie La Thangue is a mutual person.
Active
Global Cancer Consultants Limited
Prof Nicholas Barrie La Thangue is a mutual person.
Active
See All Mutual Companies
Financials
Net Assets, Total Assets & Total Liabilities (2015–2024)
Period Ended
31 Dec 2024
For period
1 Jul
⟶
31 Dec 2024
Traded for
18 months
Cash in Bank
£225.49K
Increased by £141.49K (+168%)
Turnover
Unreported
Same as previous period
Employees
7
Decreased by 1 (-13%)
Total Assets
£489.86K
Increased by £56.86K (+13%)
Total Liabilities
-£25.82K
Decreased by £1.23M (-98%)
Net Assets
£464.04K
Increased by £1.29M (-156%)
Debt Ratio (%)
5%
Decreased by 284.8% (-98%)
See 10 Year Full Financials
Latest Activity
Full Accounts Submitted
1 Month Ago on 23 Sep 2025
Confirmation Submitted
4 Months Ago on 26 Jun 2025
William John Robert Fleming Resigned
1 Year 1 Month Ago on 18 Sep 2024
Accounting Period Extended
1 Year 4 Months Ago on 2 Jul 2024
Confirmation Submitted
1 Year 4 Months Ago on 28 Jun 2024
Registers Moved To Inspection Address
1 Year 5 Months Ago on 24 May 2024
Inspection Address Changed
1 Year 5 Months Ago on 24 May 2024
Full Accounts Submitted
2 Years 1 Month Ago on 26 Sep 2023
Confirmation Submitted
2 Years 4 Months Ago on 27 Jun 2023
David James Kerr Resigned
2 Years 8 Months Ago on 21 Feb 2023
Get Alerts
Get Credit Report
Discover Celleron Therapeutics Limited's Credit Score, how much credit you can offer them, and how likely they are to repay you
See All Credit Score & Limits
Documents
Total exemption full accounts made up to 31 December 2024
Submitted on 23 Sep 2025
Confirmation statement made on 24 June 2025 with no updates
Submitted on 26 Jun 2025
Statement by Directors
Submitted on 31 Dec 2024
Solvency Statement dated 31/12/24
Submitted on 31 Dec 2024
Statement of capital on 31 December 2024
Submitted on 31 Dec 2024
Resolutions
Submitted on 31 Dec 2024
Termination of appointment of William John Robert Fleming as a director on 18 September 2024
Submitted on 19 Sep 2024
Current accounting period extended from 30 June 2024 to 31 December 2024
Submitted on 2 Jul 2024
Confirmation statement made on 24 June 2024 with no updates
Submitted on 28 Jun 2024
Register inspection address has been changed to 3rd Floor 1 Ashley Road Altrincham Cheshire WA14 2DT
Submitted on 24 May 2024
Explore All Documents
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year
See All Charges & CCJs